greeksoup/ stock research

Hancock Whitney Corp.: Q4 FY2025 earnings call

What management said about Q4 FY2025, from the documents filed with the SEC on 20 January 2026: press release. Guidance figures: 1 new. The quarter’s numbers.

Key takeaways

  • Net income and EPS held steady: Net income was $125.6 million, or $1.49 diluted EPS, against $127.5 million and $1.49 in the third quarter of 2025. The fourth quarter of 2024 was $122.1 million. Source
  • Loans rose 2% on healthcare: Total loans were $24.0 billion, up $361.9 million or 2%, with growth led by healthcare production, ICRE activity and equipment finance. Source
  • Net interest margin slipped 1 bp: NIM was 3.48%, down 1 bp, as lower loan yields (-10 bps) were partly offset by higher securities yield (+2 bps) and lower cost of funds (+7 bps). Source
  • Noninterest expense rose 2%: Noninterest expense was $217.9 million, up $5.1 million or 2%. Personnel expense was $122.5 million, up less than 1%. Source
  • Provision edged up to $13.1M: Provision for credit losses was $13.1 million, compared with $12.7 million in the third quarter of 2025. Source
  • Net charge-offs were 0.22%: Net charge-offs were $13.0 million, or 0.22% of average loans annualized, up from $11.4 million or 0.19% in the third quarter. Source
  • Criticized commercial loans declined: Criticized commercial loans were $535.4 million, or 2.88% of commercial loans, down from $549.2 million or 3.01%. Source
  • CET1 ratio fell 43 bps: CET1 was estimated at 13.66%, down 43 bps. Total risk-based capital was 15.46%, down 46 bps, and the TCE ratio was 10.06%, up 5 bps. Source
  • Repurchased 2.5 million shares: The company repurchased 2,543,700 shares at an average of $57.62, against a prior program authorization of 4,306,200 shares. Source

“The fourth quarter of 2025 marked a strong finish to a remarkable year,”

John M. Hairston, President & CEO

Guidance

AreaPeriodFigureAgainst last quarter
Share repurchases SourceJanuary 1, 2026 to December 31, 2026up to 4,112,966 shares, 5% of shares outstanding at December 31, 2025New

What changed from last quarter

  • New guidance: The previous release gave a 2025 loan growth expectation. This release gives 2026 period-end loan and deposit expectations instead.
  • New: A bond portfolio restructuring was recently completed and announced with these results. The release gives no size or accounting figures for it. Source
  • Ended: The prior share buyback program, authorized for up to 4,306,200 shares, was fully exhausted during the fourth quarter of 2025. Source

Fourth quarter and full-year results

  • Net income and EPS held steady: Net income was $125.6 million, or $1.49 diluted EPS, against $127.5 million and $1.49 in the third quarter of 2025. The fourth quarter of 2024 was $122.1 million. Source
  • Adjusted PPNR slipped slightly: Adjusted pre-provision net revenue was $174.0 million, compared with $175.6 million in the prior quarter. Source
  • 2025 adjusted EPS and PPNR grew: For full-year 2025, the CEO cited adjusted EPS up 8%, adjusted PPNR up 6% and tangible book value per share up 12%. Source

Loans and deposit balances

  • Loans rose 2% on healthcare: Total loans were $24.0 billion, up $361.9 million or 2%, with growth led by healthcare production, ICRE activity and equipment finance. Source
  • Average loans edged up 1%: Average loans were $23.7 billion, up $289.9 million or 1% from the third quarter. Source
  • Noninterest-bearing deposits were 35% of total: Noninterest-bearing DDAs were $10.4 billion, up $69.7 million or 1%, making up 35% of period-end deposits. Source
  • Interest-bearing transaction deposits grew 2%: Interest-bearing transaction and savings deposits rose $223.4 million, or 2%, which management attributed to competitive products and pricing. Source

“we believe we enter 2026 well-positioned for continued growth and enhanced shareholder value.”

John M. Hairston, President & CEO

Net interest income and margin

  • Net interest income rose 1%: Net interest income (TE) was $284.7 million, up $2.4 million or 1% from the third quarter of 2025. Source
  • Net interest margin slipped 1 bp: NIM was 3.48%, down 1 bp, as lower loan yields (-10 bps) were partly offset by higher securities yield (+2 bps) and lower cost of funds (+7 bps). Source
  • Management pursuing further margin gains: Management said it continues to pursue margin enhancement, after the NIM decline of 1 basis point. Source

Fees, expenses and efficiency

  • Noninterest income rose 1%: Noninterest income was $107.1 million, up $1.1 million or 1% from the third quarter of 2025. Source
  • Other income helped by SBIC: Other noninterest income was $19.0 million, up $2.2 million or 13%, mainly on higher SBIC income, partly offset by lower syndication fees. Source
  • Noninterest expense rose 2%: Noninterest expense was $217.9 million, up $5.1 million or 2%. Personnel expense was $122.5 million, up less than 1%. Source
  • Other expense rose 5%: Other expense was $73.6 million, up $3.5 million or 5% from the third quarter of 2025. Source
  • Efficiency ratio edged higher: Efficiency ratio was 54.93%, compared with 54.10% in the third quarter of 2025. Source
  • FTE headcount rose modestly: FTE headcount was 3,627, up from 3,603 at September 30, 2025. Source

Asset quality and credit provisions

  • Provision edged up to $13.1M: Provision for credit losses was $13.1 million, compared with $12.7 million in the third quarter of 2025. Source
  • Net charge-offs were 0.22%: Net charge-offs were $13.0 million, or 0.22% of average loans annualized, up from $11.4 million or 0.19% in the third quarter. Source
  • ACL ratio eased to 1.43%: The total ACL was $341.7 million at December 31, 2025. The ratio of ACL to period-end loans was 1.43%, compared with 1.45%. Source
  • Criticized commercial loans declined: Criticized commercial loans were $535.4 million, or 2.88% of commercial loans, down from $549.2 million or 3.01%. Source
  • Nonaccrual loans declined: Nonaccrual loans were $106.9 million, or 0.45% of total loans, down from $113.6 million or 0.48% in the third quarter. Source
  • Foreclosed assets increased: ORE and foreclosed assets rose to $14.8 million from $11.1 million in the third quarter. Source

Capital, buybacks and dividends

  • CET1 ratio fell 43 bps: CET1 was estimated at 13.66%, down 43 bps. Total risk-based capital was 15.46%, down 46 bps, and the TCE ratio was 10.06%, up 5 bps. Source
  • Repurchased 2.5 million shares: The company repurchased 2,543,700 shares at an average of $57.62, against a prior program authorization of 4,306,200 shares. Source
  • Dividend held at $0.45: Cash dividends were $0.45 per share, the same as the prior quarter, and $1.80 for the full year. Source

Figures management reported

FigureReported
Net interest margin Source3.48% (TE), down 1 bp linked-quarter
Net interest income Source$284.7 million (TE), up $2.4 million
Loans Source$24.0 billion period-end, up $361.9 million (2%)
Deposits Source$29.3 billion period-end, up $620.0 million (2%)
Provision for credit losses Source$13.1 million
Net charge-offs Source$13.0 million; 0.22% of average loans, annualized
Nonperforming assets SourceNonaccrual loans $106.9 million (0.45% of loans); ORE and foreclosed assets $14.8 million
CET1 ratio Source13.66% (estimated), down 43 bps
Efficiency ratio Source54.93%, compared with 54.10% in the prior quarter

Risks management discussed

  • Demand: Retail time deposits fell on maturity concentration and promotional rate reductions, per management. Source
  • Financial: Interest-bearing public fund balances rise and fall with seasonal inflows and outflows, which management cited as the driver of the period change. Source
  • Demand: Investment and annuity fees and insurance income fell 13% linked-quarter on lower annuity sales. Source

Earlier plans management reported on

  • Met: Management said it fully used its existing share repurchase authority in the fourth quarter of 2025. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.